Cytokinetics CYTK Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's software and technology licenses, net?
- Cytokinetics (CYTK) reported software and technology licenses, net of $18.47M in Q1 2026.
- How has Cytokinetics's software and technology licenses, net changed year-over-year?
- Cytokinetics's software and technology licenses, net increased by 45.5% year-over-year, from $12.7M to $18.47M.
- What is the long-term trend for Cytokinetics's software and technology licenses, net?
- Over 5 years (2020 to 2025), Cytokinetics's software and technology licenses, net has grown at a 22.2% compound annual growth rate (CAGR), from $6.36M to $17.34M.